Novartis Bioventures Ltd
An insider at 2 companies in coverage, as reported on Form 4. SEC CIK 1297709. Latest Form 4 filed May 31, 2019.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Bicycle Therapeutics plcBCYC | 10% owner | 7 | 2019-05-28 | 2019-05-28 |
| Altimmune, Inc.ALT | 10% owner | 27 | 2017-08-21 | 2018-09-12 |
Transactions: 34
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2019-05-28 | Bicycle Therapeutics plc10% owner | ConversionSeries B1 Preferred Shares | 636,366 | not reported | not reported | Form 4 |
| 2019-05-28 | Bicycle Therapeutics plc10% owner | Option exercise (in the money)Series A Preferred Shares Warrants | 71,450 | not reported | not reported | Form 4 |
| 2019-05-28 | Bicycle Therapeutics plc10% owner | ConversionSeries A Preferred Shares | 893,195 | not reported | not reported | Form 4 |
| 2019-05-28 | Bicycle Therapeutics plc10% owner | Purchase | 168,630 | $14.00 | $2.4m | Form 4 |
| 2019-05-28 | Bicycle Therapeutics plc10% owner | Conversion | 636,366 | not reported | not reported | Form 4 |
| 2019-05-28 | Bicycle Therapeutics plc10% owner | Option exercise (in the money) | 71,450 | not reported | not reported | Form 4 |
| 2019-05-28 | Bicycle Therapeutics plc10% owner | Conversion | 893,195 | not reported | not reported | Form 4 |
| 2018-09-12 | Altimmune, Inc.10% owner | OtherWarrants | 465,086 | not reported | not reported | Form 4 |
| 2018-09-12 | Altimmune, Inc.10% owner | Other | 2,069,993 | not reported | not reported | Form 4 |
| 2018-07-11 | Altimmune, Inc.10% owner | OtherSeries B Convertible Preferred Stock | 344.929 | $940.00 | $324.2k | Form 4 |
| 2018-07-11 | Altimmune, Inc.10% owner | Other | 663,346 | not reported | not reported | Form 4 |
| 2018-06-15 | Altimmune, Inc.10% owner | Other | 14,449 | not reported | not reported | Form 4 |
| 2018-06-13 | Altimmune, Inc.10% owner | OtherSeries B Convertible Preferred Stock | 344.94 | not reported | not reported | Form 4 |
| 2018-06-13 | Altimmune, Inc.10% owner | Other | 720,878 | not reported | not reported | Form 4 |
| 2018-05-16 | Altimmune, Inc.10% owner | OtherSeries B Convertible Preferred Stock | 344.94 | not reported | not reported | Form 4 |
| 2018-05-16 | Altimmune, Inc.10% owner | Other | 767,728 | not reported | not reported | Form 4 |
| 2018-05-15 | Altimmune, Inc.10% owner | Other | 274,703 | not reported | not reported | Form 4 |
| 2018-04-16 | Altimmune, Inc.10% owner | OtherSeries B Convertible Preferred Stock | 344.94 | not reported | not reported | Form 4 |
| 2018-04-16 | Altimmune, Inc.10% owner | Other | 217,159 | not reported | not reported | Form 4 |
| 2018-04-16 | Altimmune, Inc.10% owner | Other | 482,907 | not reported | not reported | Form 4 |
| 2018-03-15 | Altimmune, Inc.10% owner | OtherSeries B Convertible Preferred Stock | 344.94 | not reported | not reported | Form 4 |
| 2018-03-15 | Altimmune, Inc.10% owner | Other | 261,969 | not reported | not reported | Form 4 |
| 2018-02-15 | Altimmune, Inc.10% owner | Other | 67,925 | not reported | not reported | Form 4 |
| 2018-02-13 | Altimmune, Inc.10% owner | OtherSeries B Convertible Preferred Stock | 344.94 | not reported | not reported | Form 4 |
| 2018-02-13 | Altimmune, Inc.10% owner | Other | 269,527 | not reported | not reported | Form 4 |
| 2018-01-17 | Altimmune, Inc.10% owner | OtherSeries B Convertible Preferred Stock | 344.94 | not reported | not reported | Form 4 |
| 2018-01-17 | Altimmune, Inc.10% owner | Other | 176,586 | not reported | not reported | Form 4 |
| 2017-12-15 | Altimmune, Inc.10% owner | Other | 65,718 | not reported | not reported | Form 4 |
| 2017-12-13 | Altimmune, Inc.10% owner | OtherSeries B Convertible Preferred Stock | 344.94 | not reported | not reported | Form 4 |
| 2017-12-13 | Altimmune, Inc.10% owner | Other | 242,694 | not reported | not reported | Form 4 |
| 2017-11-14 | Altimmune, Inc.10% owner | OtherSeries B Convertible Preferred Stock | 344.94 | not reported | not reported | Form 4 |
| 2017-11-14 | Altimmune, Inc.10% owner | Other | 182,262 | not reported | not reported | Form 4 |
| 2017-08-21 | Altimmune, Inc.10% owner | PurchaseWarrant | 465,086 | not reported | not reported | Form 4 |
| 2017-08-21 | Altimmune, Inc.10% owner | PurchaseSeries B Convertible Preferred Stock | 3,104.447 | $940.00 | $2.9m | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 30, 2026, 03:56 ET. Listed shows no prices and gives no investment advice.